Citius Pharmaceuticals (CTXR) Receivables (2025 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Receivables came in at $1.1 million in Q1 2026, down 73.35% on a QoQ basis from $4.0 million in Q4 2025.
Citius Pharmaceuticals (CTXR) Receivables (2025 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 2 years of Receivables data on file, last reported at $1.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | - |
| 10 | Citius Pharmaceuticals | 15.96 Mn | 15.96 Mn | 1.00 Mn | 686,235.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 4.05 Mn |